Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
about
Inhibin A and inhibin B producing ovarian fibrothecoma revealed by suppression of follicle stimulating hormone (FSH) in a post-menopausal woman: report of the first case.Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma
P2860
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@ast
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@en
type
label
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@ast
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@en
prefLabel
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@ast
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@en
P2093
P2860
P1433
P1476
Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients.
@en
P2093
Alina Sokup
Aneta Mankowska-Cyl
Magdalena Krintus
Malgorzata Walentowicz-Sadlecka
Marek Grabiec
Pawel Sadlecki
Pawel Walentowicz
P2860
P304
P356
10.1371/JOURNAL.PONE.0090575
P407
P577
2014-03-05T00:00:00Z